Kinetiq VP Talks 21st Century Cures Act With Senator Patty Murray
This year, at Life Science Innovation Washington Kinetiq VP of Legal and Regulatory Affairs, Mitchell Parrish, sat down with Senator Patty Murray at a round table with nine other Life Science Executives. Mitchell shared how Kinetiq continues to leverage the 21st Century Cures Act to help its clients move their research forward. This includes enabling massive post marketing studies for life changing devices and approval of first ever digital therapeutics in the fight against opioid dependency. Kinetiq applauds Senator Murray’s efforts and looks forward to the FDA continuing to execute the Act’s directives.